Prefilled Syringes or Peptide Pills? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Prefilled Syringes or Peptide Pills?
The impact of new delivery technologies in designing peptide therapies.


Pharmaceutical Technology
Volume 37, Issue 5, pp. 46-49

12. A. Lalatsa et al., Mol. Pharm. 9 (6) 1764-1774 (2012).

13. A. Lalatsa et al., Mol. Pharm. 9 (6) 1665-1680 (2012).

14. J. Oberye et al., Hum. Reprod. 15 (2) 245-249 (2000).

15. L.R. Brown, Expert Opin. Drug Deliv. 2 (1) 29-42 (2005).

16. D.R. Serrano-Lopez and A. Lalatsa, Ther. Deliv. 4 (4) 479-501 (2013).

17. N. Parquet et al., Bone Marrow Transplant 25 (9) 965-968 (2000).

18. J. Shaji and V. Patole, Indian J Pharm. Sci. 70 (3) 269-277 (2008).

19. A. Keegan, Diabetes Forecast 60 (13) 19 (2007).

20. D. Jha et al., Bioconjug. Chem. 22 (3) 319-328 (2011).

21. I. Berezowska et al., J Med. Chem. 50 (6) 1414-1417 (2007).

22. Z. Yan et al., Mol. Pharm. 8 (2) 319-329 (2011).

23. A. Bernkop-Schnurch, J Control. Rel. 52 (1-2) 1-16 (1998).

24. H. Tozaki et al., J Pharm. Pharmacol. 49 (2) 164-168 (1997).

25. V. Khutoryanskiy, Macromol. Biosci. 11 (6) 748-764 (2011).

26. B.T. Griffin and C. M. O'Driscoll, Ther. Deliv. 2 (12) 1633-1653 (2011).

27. S. Schwartz et al., Diabetes 57 (S1) A124 (2008).

28. A.K. Petrus et al., Angew. Chem. Int. Ed. Engl. 48 (6) 1022-1028 (2009).

29. A.K. Petrus et al., ChemMedChem 2 (12) 1717-1721 (2007).

30. B.A. Sabel and U. Schroeder, "Drug Targeting System, Method of Its Preparation and Use," PCT/EP1997/003099 (1997).

31. NOD Pharmaceuticals website, "NOD Tech: Enable Oral Delivery of Biopharmaceuticals," http://www.nodpharm.com/nodtech.html, accessed Apr. 4 2013.

32. U. Schroeder et al., Peptides 19 (4) 777-780 (1998).

33. D. Das and S. Lin, J Pharm. Sci. 94 (6) 1343-1353 (2005).

34. Nanomerics website, "Molecular Envelope Technology," http://www.nanomerics.com/, accessed Apr. 4, 2013.

Aikaterini Lalatsa, PhD, is a lecturer in pharmaceutics and drug delivery at the School of Pharmacy, University of Hertfordshire, College Lane Campus, Hatfield, Hertfordshire, AL10 9AB, United Kingdom.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here